Bivigam

Product manufactured by Adma Biologics, Inc.

Application Nr Approved Date Route Status External Links
BLA125389 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Bivigam Is An Immune Globulin Intravenous (Human), 10% Liquid, Indicated For The Treatment Of Primary Humoral Immunodeficiency (Pi). [1] 1.1 Primary Humoral Immunodeficiency Bivigam Is An Immune Globulin Intravenous (Human), 10% Liquid, Indicated For The Treatment Of Patients With Primary Humoral Immunodeficiency (Pi). This Includes, But Is Not Limited To, The Humoral Immune Defect In Common Variable Immunodeficiency (Cvid), X-Linked Agammaglobulinemia, Congenital Agammaglobulinemia, Wiskott-Aldrich Syndrome, And Severe Combined Immunodeficiencies.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Human Immunoglobulin G

Comments